Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vs Injection MMC in Trabeculectomy
NCT02744690Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Mar 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of mitomycin c in Glaucoma (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Cumulative incidence of complications at 3 months. Planned start Mar 2015; status: withdrawn.
02
Drugs
mitomycin c
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT02744690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02744690.